Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glyfloz-M 5mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Chemo Healthcare Pvt Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (500mg)

Overview Glyfloz-M 5mg/500mg Tablet ER

Diabetic patients with type 2 mellitus find relief with Glyfloz-M 5mg/500mg ER tablets, a dual-action medication controlling elevated blood glucose. This helps mitigate the risk of severe diabetic complications, including cardiovascular disease. Glyfloz-M 5mg/500mg ER tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician, and discontinuation requires their consultation, as cessation may elevate blood sugar, potentially leading to kidney damage or vision impairment. This medication is part of a comprehensive treatment plan, incorporating a doctor-recommended diet, exercise, and weight management. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to avoid dehydration. Genital fungal infections are a possibility; meticulous hygiene is advised. Prior to commencing treatment, discuss kidney or liver conditions, urinary tract infections, diuretic use, pregnancy, or breastfeeding with your physician. Limit alcohol consumption, as it may intensify side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Glyfloz-M 5mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Glyfloz-M 5mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glyfloz-M 5mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glyfloz-M 5mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glyfloz-M 5mg/500mg Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Glyfloz-M 5mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Glyfloz-M 5mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Glyfloz-M 5mg/500mg Tablet ER works:

Dapagliflozin and Metformin, combined as Glyfloz-M 5mg/500mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyfloz-M 5mg/500mg Extended-Release tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glyfloz-M 5mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glyfloz-M 5mg/500mg tablets are likely unsafe for breastfeeding mothers. Preliminary human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glyfloz-M 5mg/500mg Extended-Release tablets to individuals with impaired renal function. Dosage modification of Glyfloz-M 5mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Glyfloz-M 5mg/500mg Extended-Release tablets. Dosage modification of Glyfloz-M 5mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Glyfloz-M 5mg/500mg Tablet ER :

Should you forget a Glyfloz-M 5mg/500mg Extended-Release tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyfloz-M 5mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Glyfloz-M 5mg/500mg Table...
131
MRP 159
17% off